Tissue plasminogen activator therapy for the eye

被引：15
作者：
Tripathi, RC [1 ]
Tripathi, BJ [1 ]
机构：
[1] Univ S Carolina, Sch Med, Dept Ophthalmol, Vis Res Labs, Columbia, SC 29209 USA
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2005年 / 89卷 / 11期
关键词：
D O I：
10.1136/bjo.2005.074401
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1390 / 1391
页数：2
相关论文
共 42 条
[1]  
ABRAMS GW, 1991, INVEST OPHTH VIS SCI, V32, P1226
[2]  
BAKER ND, 1991, INVEST OPHTH VIS SCI, V32, P1122
[3]  
BRAMSEN T, 1978, ACTA OPHTHALMOL, V56, P1006
[4]  
CELLINI M, 1994, INT OPHTHALMOL, V18, P351
[5]   Retinal toxicity of intravitreal tissue plasminogen activator [J].
Chen, SN ;
Yang, TC ;
Ho, CL ;
Kuo, YH ;
Yip, Y ;
Chao, AN .
OPHTHALMOLOGY, 2003, 110 (04) :704-708
[6]   Tissue-type plasminogen activator: a historical perspective and personal account [J].
Collen, D ;
Lijnen, HR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :541-546
[7]   COMPLICATIONS OF TISSUE PLASMINOGEN-ACTIVATOR THERAPY AFTER VITRECTOMY FOR DIABETES [J].
DABBS, CK ;
AABERG, TM ;
AGUILAR, HE ;
STERNBERG, P ;
MEREDITH, TA ;
WARD, AR .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 110 (04) :354-360
[8]  
Erol N, 2003, OPHTHAL SURG LAS IM, V34, P451
[9]  
Fallaha N, 2001, Ophthalmol Clin North Am, V14, P479, DOI 10.1016/S0896-1549(05)70246-7
[10]  
Forrester J V, 1974, Trans Ophthalmol Soc U K, V94, P583
12345